Key facts
- The Trump administration has secured drug-pricing agreements with over 20 pharmaceutical companies.
- Companies are offering discounts through platforms like TrumpRx.gov and to Medicaid beneficiaries.
- Some companies have pledged U.S. investment in exchange for clarity on pricing measures or tariff relief.
- Specific deals include price reductions for drugs like Ozempic, Wegovy, Eliquis, and various fertility treatments.
U.S. President Donald Trump has secured drug-pricing agreements with more than 20 pharmaceutical companies, aiming to reduce prescription costs for American patients. These deals, part of an initiative to make U.S. drug prices more competitive with those in other developed countries, involve various commitments from the participating companies.
The agreements include measures such as offering discounts through the TrumpRx.gov platform, providing lower prices to Medicaid programs, and expanding direct-to-patient sales channels. Some companies have also pledged U.S. investment or job creation in exchange for clarity on pricing policies or potential tariff relief.
Notable participants include Pfizer, which agreed to discounts of up to 85% on primary care treatments and select brands; Novo Nordisk, which will offer its semaglutide medicines like Ozempic and Wegovy at $350 per month; and Eli Lilly, which will cap obesity medicines for Medicare beneficiaries at $50 per month.
Other companies like Bristol Myers Squibb have committed to providing certain drugs, such as Eliquis, to Medicaid for free. Regeneron will lower the price of its cholesterol drug Praluent to $225 from $537 for direct purchases via TrumpRx. CSL, an Australian company, will invest $1.5 billion in Illinois manufacturing, creating over 1,100 jobs, as part of its agreement.
A spokesperson for the pharmaceutical industry emphasized that these are individual company decisions rather than government mandates. The deals represent a continuation of the administration's efforts to address high prescription drug costs in the United States.